Access Vascular Revenue and Competitors
Estimated Revenue & Valuation
- Access Vascular's estimated annual revenue is currently $6.5M per year.
- Access Vascular's estimated revenue per employee is $151,767
- Access Vascular's total funding is $35.1M.
Employee Data
- Access Vascular has 43 Employees.
- Access Vascular grew their employee count by 13% last year.
Access Vascular Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.8M | 37 | 0% | N/A | N/A |
#2 | $3M | 23 | 0% | N/A | N/A |
#3 | $4M | 14 | 8% | N/A | N/A |
#4 | $4.5M | 14 | -12% | N/A | N/A |
#5 | $5630M | 6953 | 4% | $450M | N/A |
#6 | $4M | 14 | 8% | N/A | N/A |
#7 | $6.8M | 44 | 19% | $29.6M | N/A |
#8 | $12.6M | 49 | 26% | N/A | N/A |
#9 | $2M | 13 | 8% | $44M | N/A |
#10 | $54.6M | 207 | 16% | N/A | N/A |
What Is Access Vascular?
Access Vascular is developing a suite of venous access devices that use our novel, patented biomaterial which is designed to prevent the most common and costly complications in venous access. Our first product, FDA-cleared HydroPICC, has demonstrated a 30x reduction in thrombosis versus a standard polyurethane catheter.* *Data on file at Access Vascular. Reduction of thrombosis accumulation was evaluated using in vitro and in vivo models.
keywords:N/A
$35.1M
Total Funding
43
Number of Employees
$6.5M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Access Vascular News
Vascular Access Catheters Market Global Industry Research Analysis & Forecast 2022 to 2027 | Biomerics, Teleflex, Medcomp, Access Vascular
Bedside Peripheral Ultrasound-Guided Vascular Access in 253 Patients Hospitalized With COVID-19 Pneumonia: A Retrospective Italian Study.
Access Vascular, Inc. Opens New Facility Outside Boston With Expanded Production Capacity to Meet Growing Demand for Its Biomaterial Devices.
Bedford, MA – 03 March, 2021- Access Vascular, Inc., a company addressing the most common and costly venous access complications, today announced it has closed on a Series B round of financing. TVM Capital Life Science led the round with a $15 million commitment, with existing investors also pa ...
Other Companies in Bedford
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.1M | 43 | 8% | N/A |
#2 | $10.3M | 43 | -7% | N/A |
#3 | $6.8M | 44 | 19% | $29.6M |
#4 | $14.3M | 44 | N/A | N/A |
#5 | $3.5M | 44 | 10% | N/A |